MQS Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

MQS Management’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-4,614	Closed	-$250K	–	427
2025 Q3	$250K	Buy	+4,614	New	+$264K	0.15%	312
2024 Q3	–	Sell	-6,818	Closed	-$561K	–	457
2024 Q2	$561K	Buy	+6,818	New	+$568K	0.34%	87
2023 Q4	–	Sell	-4,015	Closed	-$355K	–	472
2023 Q3	$355K	Buy	4,015 +115	+3%	+$10.2K	0.22%	200
2023 Q2	$338K	Sell	3,900 -357	-8%	-$33.6K	0.23%	177
2023 Q1	$414K	Buy	+4,257	New	+$441K	0.27%	141
2022 Q3	–	Sell	-4,374	Closed	-$362K	–	421
2022 Q2	$362K	Sell	4,374 -678	-13%	-$54K	0.25%	169
2022 Q1	$390K	Buy	+5,052	New	+$423K	0.32%	125

Other funds holding BMRN

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Viking Global Investors

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return